Bristol melanoma drug combo marks new advance in immunotherapy
By Julie Steenhuysen CHICAGO (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those ...
Read More »By Julie Steenhuysen CHICAGO (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those ...
Read More »By Deena Beasley (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer h...
Read More »
By Bill Berkrot (Reuters) - An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer...
Read More »
(Reuters) - The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulce...
Read More »
By David Morgan WASHINGTON (Reuters) - The U.S. Senate on Wednesday confirmed Marilyn Tavenner, a former nurse and hospital company ...
Read More »By Tom Miles GENEVA (Reuters) - People are living longer than ever and "dramatic" gains in life expectancy show no sign of slowing d...
Read More »By Jessica Toonkel NEW YORK (Reuters) - Before Optimer Pharmaceuticals Inc even put itself up for sale earlier this year, Cubist Pha...
Read More »
By Jessica Toonkel NEW YORK (Reuters) - Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, t...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers s...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Music, art and dance therapy may relieve anxiety and similar symptoms among people wi...
Read More »